首页 > 最新文献

Medical sciences (Basel, Switzerland)最新文献

英文 中文
Association Between Asian Flush and Satisfaction of Sleep via Alcohol Consumption Status in a Sample of Japanese Participants. 在日本参与者样本中,通过饮酒状况观察亚洲人的潮红与睡眠满意度之间的关系。
Q1 Medicine Pub Date : 2024-11-08 DOI: 10.3390/medsci12040062
Yuji Shimizu, Tomokatsu Yoshida, Keiko Ito, Kumiko Terada, Nagisa Sasaki, Eiko Honda, Kazushi Motomura

Background: The reddening of the face and neck following alcohol consumption is known as Asian flush. Although genetic factors related to Asian flush have been reported to be inversely associated with duration of sleep, no study has reported an association between Asian flush and sleep satisfaction.

Methods: A cross-sectional study of 3823 Japanese people, aged 20 to 64 years was conducted. The target population comprised general public resident monitors of Osaka Prefecture who were registered with an internet research company.

Results: A significant inverse association was observed between Asian flush and satisfaction of sleep. The potential confounder-adjusted odds ratio (OR) and 95% confidence interval (CI) of satisfied sleep was 0.81 (0.69-0.96). The alcohol consumption status-specific analysis revealed essentially the same associations between consumers and non-consumers of alcohol. The adjusted ORs (95% CIs) were 0.81 (0.65-0.997) for non-consumers and 0.80 (0.61-1.05) for consumers of alcohol.

Conclusion: The genetic characteristics of physical reactions to alcohol exposure may influence sleep quality. One's alcohol consumption status may not influence the effects of having a lower tolerance to alcohol on sleep quality.

背景介绍饮酒后脸部和颈部发红被称为亚洲潮红。尽管有报告称,与亚洲潮红有关的遗传因素与睡眠时间的长短成反比,但还没有研究报告称亚洲潮红与睡眠满意度之间存在关联:方法:对 3823 名 20 至 64 岁的日本人进行了横断面研究。研究对象是在一家互联网调查公司注册的大阪府普通居民:结果发现,亚洲人的潮红与睡眠满意度之间存在明显的反比关系。经潜在混杂因素调整后,睡眠满意度的几率比(OR)和 95% 置信区间(CI)为 0.81(0.69-0.96)。针对饮酒状况的分析显示,饮酒者与非饮酒者之间的关联基本相同。非饮酒者的调整ORs(95% CIs)为0.81(0.65-0.997),饮酒者的调整ORs(95% CIs)为0.80(0.61-1.05):结论:身体对酒精反应的遗传特征可能会影响睡眠质量。一个人的饮酒状况可能不会影响对酒精耐受性较低的人对睡眠质量的影响。
{"title":"Association Between Asian Flush and Satisfaction of Sleep via Alcohol Consumption Status in a Sample of Japanese Participants.","authors":"Yuji Shimizu, Tomokatsu Yoshida, Keiko Ito, Kumiko Terada, Nagisa Sasaki, Eiko Honda, Kazushi Motomura","doi":"10.3390/medsci12040062","DOIUrl":"10.3390/medsci12040062","url":null,"abstract":"<p><strong>Background: </strong>The reddening of the face and neck following alcohol consumption is known as Asian flush. Although genetic factors related to Asian flush have been reported to be inversely associated with duration of sleep, no study has reported an association between Asian flush and sleep satisfaction.</p><p><strong>Methods: </strong>A cross-sectional study of 3823 Japanese people, aged 20 to 64 years was conducted. The target population comprised general public resident monitors of Osaka Prefecture who were registered with an internet research company.</p><p><strong>Results: </strong>A significant inverse association was observed between Asian flush and satisfaction of sleep. The potential confounder-adjusted odds ratio (OR) and 95% confidence interval (CI) of satisfied sleep was 0.81 (0.69-0.96). The alcohol consumption status-specific analysis revealed essentially the same associations between consumers and non-consumers of alcohol. The adjusted ORs (95% CIs) were 0.81 (0.65-0.997) for non-consumers and 0.80 (0.61-1.05) for consumers of alcohol.</p><p><strong>Conclusion: </strong>The genetic characteristics of physical reactions to alcohol exposure may influence sleep quality. One's alcohol consumption status may not influence the effects of having a lower tolerance to alcohol on sleep quality.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the Matrix of Factor V Leiden (G1691A), Factor II Prothrombin (G2021A), MTHFR C677T and A1298G Polymorphisms in Greek Population: A Preliminary Study. 调查希腊人群中因子 V Leiden (G1691A)、因子 II Prothrombin (G2021A)、MTHFR C677T 和 A1298G 多态性的基质:初步研究。
Q1 Medicine Pub Date : 2024-11-05 DOI: 10.3390/medsci12040061
Maria Spanoudaki, Aikaterini Itziou, Antonios Cheimaras, Orestis Tsiripidis, Grigoris Risvas, Naysika Tsitlakidou, Vasileios Balis

Background: Thrombophilia, characterized by an increased risk of thrombosis, can result from genetic polymorphisms in clotting factors. This study aims to investigate the prevalence of factor V Leiden (G1691A), factor II prothrombin (G20210A), and MTHFR (C677T and A1298C) polymorphisms in a Greek population, evaluating not only their association with thrombophilia, but also broader health implications.

Methods: We conducted a cross-sectional study involving one hundred apparently healthy adults from Thessaloniki, Greece. After obtaining informed consent, DNA was isolated and analyzed using real-time PCR to detect the frequencies of the aforementioned polymorphisms.

Results: The genetic distribution of the examined polymorphisms aligns closely with that observed in Northern Europe. Factor V Leiden (FVL) and prothrombin G20210A mutations were predominantly wild types, with a small percentage showing heterozygous mutations. The MTHFR C677T and A1298C polymorphisms showed a higher variation in allele frequency. Certain lifestyle factors such as smoking and high body mass index were significantly associated with the occurrence of combined MTHFR genotypes, suggesting an interaction between genetic and environmental risk factors. Family cancer and cardiovascular history was significantly associated with combined FVL and prothrombin G20210A and MTHFR polymorphism heterozygous carriers.

Conclusions: Our findings indicate that these genetic polymorphisms are not only pivotal in understanding thrombophilia but also have broader implications for cardiovascular disease and cancer. This study highlights the need for further research into the combined effects of genetic and epigenetic factors on health, which could lead to improved screening and personalized preventive healthcare strategies.

背景:凝血因子的基因多态性可导致血栓形成风险增加的血栓性疾病。本研究旨在调查希腊人群中因子 V Leiden(G1691A)、因子 II 凝血酶原(G20210A)和 MTHFR(C677T 和 A1298C)多态性的患病率,不仅评估它们与血栓性疾病的关系,还评估其对健康的广泛影响:我们进行了一项横断面研究,涉及希腊塞萨洛尼基的 100 名表面健康的成年人。在获得知情同意后,我们分离了 DNA,并使用实时 PCR 分析方法检测上述多态性的频率:结果:检测的多态性基因分布与北欧观察到的分布密切相关。因子 V Leiden(FVL)和凝血酶原 G20210A 突变主要为野生型,小部分为杂合型。MTHFR C677T 和 A1298C 多态性的等位基因频率变化较大。某些生活方式因素(如吸烟和高体重指数)与合并 MTHFR 基因型的发生显著相关,这表明遗传和环境风险因素之间存在相互作用。家族癌症和心血管病史与合并 FVL 和凝血酶原 G20210A 及 MTHFR 多态性杂合子携带者明显相关:我们的研究结果表明,这些基因多态性不仅是了解血栓性疾病的关键,而且对心血管疾病和癌症有更广泛的影响。这项研究强调,有必要进一步研究遗传和表观遗传因素对健康的综合影响,从而改进筛查和个性化预防保健策略。
{"title":"Investigating the Matrix of Factor V Leiden (G1691A), Factor II Prothrombin (G2021A), MTHFR C677T and A1298G Polymorphisms in Greek Population: A Preliminary Study.","authors":"Maria Spanoudaki, Aikaterini Itziou, Antonios Cheimaras, Orestis Tsiripidis, Grigoris Risvas, Naysika Tsitlakidou, Vasileios Balis","doi":"10.3390/medsci12040061","DOIUrl":"10.3390/medsci12040061","url":null,"abstract":"<p><strong>Background: </strong>Thrombophilia, characterized by an increased risk of thrombosis, can result from genetic polymorphisms in clotting factors. This study aims to investigate the prevalence of factor V Leiden (G1691A), factor II prothrombin (G20210A), and MTHFR (C677T and A1298C) polymorphisms in a Greek population, evaluating not only their association with thrombophilia, but also broader health implications.</p><p><strong>Methods: </strong>We conducted a cross-sectional study involving one hundred apparently healthy adults from Thessaloniki, Greece. After obtaining informed consent, DNA was isolated and analyzed using real-time PCR to detect the frequencies of the aforementioned polymorphisms.</p><p><strong>Results: </strong>The genetic distribution of the examined polymorphisms aligns closely with that observed in Northern Europe. Factor V Leiden (FVL) and prothrombin G20210A mutations were predominantly wild types, with a small percentage showing heterozygous mutations. The MTHFR C677T and A1298C polymorphisms showed a higher variation in allele frequency. Certain lifestyle factors such as smoking and high body mass index were significantly associated with the occurrence of combined MTHFR genotypes, suggesting an interaction between genetic and environmental risk factors. Family cancer and cardiovascular history was significantly associated with combined FVL and prothrombin G20210A and MTHFR polymorphism heterozygous carriers.</p><p><strong>Conclusions: </strong>Our findings indicate that these genetic polymorphisms are not only pivotal in understanding thrombophilia but also have broader implications for cardiovascular disease and cancer. This study highlights the need for further research into the combined effects of genetic and epigenetic factors on health, which could lead to improved screening and personalized preventive healthcare strategies.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database. 美国 CMML 患者的生存结果:来自 SEER 数据库的二十年分析。
Q1 Medicine Pub Date : 2024-10-31 DOI: 10.3390/medsci12040060
Ayrton Bangolo, Behzad Amoozgar, Abhishek Thapa, Wardah Bajwa, Vignesh K Nagesh, Yaryna Nyzhnyk, Rakshanda Banu, Tirth Bhavsar, Lili Zhang, Olga Velichko, Challa Mani Shankar Reddy, Edwina Essuman, Amal M Ibrahim, Ramkumar Krishnasamy, Achint Jethi, Arun Ram, Abdullah A Haq, Abdulla Ahmad Al Hashm, Parna Pathak, Shafia Naeem, Rachana R Gavva, Prajakta H Ratnaparkhi, Paula Samaha, Cynthia Elizabeth Armendariz Espinoza, Prasansa Dhakal, Frantz Ricot Martine, Mogahid Elkhidir, Jay Mehta, Simcha Weissman

Background: Chronic Myelomonocytic Leukemia (CMML) is a rare and aggressive form of leukemia with characteristics of both myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDSs). This study aims to explore the clinical features, survival outcomes, and prognostic factors in CMML patients over the past 20 years using a large sample. Methods: The study data from 4124 patients diagnosed with CMML between 2000 and 2017 were sourced from the SEER database. Demographic and clinical characteristics, along with overall and cancer-specific mortality, were examined. Factors with a p-value < 0.01 in univariate Cox regression were included in the multivariate Cox model to identify independent prognostic factors, with hazard ratios (HRs) greater than one indicating adverse outcomes. Results: The majority of the cohort were male (61.57%), and most diagnoses occurred between ages 60-79 (55.16%), with a small percentage under 40 (1.41%). Non-Hispanic whites represented the largest racial group (79.03%). Multivariate analysis showed higher mortality in males, those aged 80+, residents in metropolitan areas with populations between 250,000 and 1 million, single or widowed individuals, and those who underwent chemotherapy. Conversely, lower mortality was associated with an annual income of $75,000+. Conclusions: CMML remains a rare and highly aggressive hematologic disorder. This U.S.-based retrospective cohort study identified male gender, advanced age, single or widowed status, and chemotherapy as independent poor prognostic factors. While it is expected that older patients and those requiring chemotherapy would have a poorer prognosis, the higher mortality risk in single or widowed patients, as well as males, warrants further investigation. The early involvement of family and community support may help reduce mortality in these groups, suggesting a need for larger prospective studies to explore these associations further.

背景:慢性粒细胞白血病(CMML慢性粒细胞白血病(CMML)是一种罕见的侵袭性白血病,同时具有骨髓增生性肿瘤(MPN)和骨髓增生异常综合征(MDS)的特征。本研究旨在使用大样本探讨 CMML 患者在过去 20 年中的临床特征、生存结果和预后因素。研究方法2000年至2017年间确诊的4124名CMML患者的研究数据来自SEER数据库。研究考察了人口统计学和临床特征,以及总死亡率和癌症特异性死亡率。在单变量Cox回归中P值小于0.01的因素被纳入多变量Cox模型,以确定独立的预后因素,危险比(HR)大于1表示不良结局。结果队列中大多数患者为男性(61.57%),大多数患者的诊断年龄在 60-79 岁之间(55.16%),40 岁以下的患者比例较小(1.41%)。非西班牙裔白人是最大的种族群体(79.03%)。多变量分析显示,男性、80 岁以上者、人口在 25 万到 100 万之间的大都市居民、单身或丧偶者以及接受过化疗者的死亡率较高。相反,年收入在 7.5 万美元以上的人死亡率较低。结论CMML仍然是一种罕见且侵袭性极强的血液病。这项基于美国的回顾性队列研究发现,男性、高龄、单身或丧偶以及化疗是预后不良的独立因素。虽然预计高龄患者和需要化疗的患者预后较差,但单身或丧偶患者以及男性患者的死亡风险较高,值得进一步研究。家庭和社区支持的早期参与可能有助于降低这些群体的死亡率,这表明有必要进行更大规模的前瞻性研究,以进一步探讨这些关联。
{"title":"Survival Outcomes of U.S. Patients with CMML: A Two-Decade Analysis from the SEER Database.","authors":"Ayrton Bangolo, Behzad Amoozgar, Abhishek Thapa, Wardah Bajwa, Vignesh K Nagesh, Yaryna Nyzhnyk, Rakshanda Banu, Tirth Bhavsar, Lili Zhang, Olga Velichko, Challa Mani Shankar Reddy, Edwina Essuman, Amal M Ibrahim, Ramkumar Krishnasamy, Achint Jethi, Arun Ram, Abdullah A Haq, Abdulla Ahmad Al Hashm, Parna Pathak, Shafia Naeem, Rachana R Gavva, Prajakta H Ratnaparkhi, Paula Samaha, Cynthia Elizabeth Armendariz Espinoza, Prasansa Dhakal, Frantz Ricot Martine, Mogahid Elkhidir, Jay Mehta, Simcha Weissman","doi":"10.3390/medsci12040060","DOIUrl":"10.3390/medsci12040060","url":null,"abstract":"<p><p><b>Background:</b> Chronic Myelomonocytic Leukemia (CMML) is a rare and aggressive form of leukemia with characteristics of both myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDSs). This study aims to explore the clinical features, survival outcomes, and prognostic factors in CMML patients over the past 20 years using a large sample. <b>Methods:</b> The study data from 4124 patients diagnosed with CMML between 2000 and 2017 were sourced from the SEER database. Demographic and clinical characteristics, along with overall and cancer-specific mortality, were examined. Factors with a <i>p</i>-value < 0.01 in univariate Cox regression were included in the multivariate Cox model to identify independent prognostic factors, with hazard ratios (HRs) greater than one indicating adverse outcomes. <b>Results:</b> The majority of the cohort were male (61.57%), and most diagnoses occurred between ages 60-79 (55.16%), with a small percentage under 40 (1.41%). Non-Hispanic whites represented the largest racial group (79.03%). Multivariate analysis showed higher mortality in males, those aged 80+, residents in metropolitan areas with populations between 250,000 and 1 million, single or widowed individuals, and those who underwent chemotherapy. Conversely, lower mortality was associated with an annual income of $75,000+. <b>Conclusions:</b> CMML remains a rare and highly aggressive hematologic disorder. This U.S.-based retrospective cohort study identified male gender, advanced age, single or widowed status, and chemotherapy as independent poor prognostic factors. While it is expected that older patients and those requiring chemotherapy would have a poorer prognosis, the higher mortality risk in single or widowed patients, as well as males, warrants further investigation. The early involvement of family and community support may help reduce mortality in these groups, suggesting a need for larger prospective studies to explore these associations further.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142712051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing NIRS and Pulse Oximetry for Cerebral Oxygen Saturation During Hypoxia Testing. 比较近红外成像技术和脉搏血氧仪在缺氧测试中的脑氧饱和度。
Q1 Medicine Pub Date : 2024-10-24 DOI: 10.3390/medsci12040059
Vasilios Alevizakos, Andreas Werner, Lisa-Marie Schiller, Constantin von See, Marcus Schiller

Objective: This study evaluates the suitability of cerebral oximetry using near-infrared spectroscopy (NIRS) compared to traditional pulse oximetry (SpO2) for measuring cerebral oxygen saturation during hypoxia testing, aiming to enhance safety during flight operations and training. Material and Methods: The study included 106 participants aged 18-60 years at the Aerospace Medicine Training Center in Königsbrück. Cerebral oxygen saturation (rSO2) and peripheral oxygen saturation (SpO2) were measured using the INVOS™ 5100C cerebral oximeter and Masimo™ MS5 pulse oximeter, respectively. Measurements were taken at baseline, during hypoxia at 25,000 feet, and post recovery. Data analysis included regression analysis, Bland-Altman plots, and concordance correlation coefficients (CCC). Ethical approval was obtained from the Hannover Medical School. Data from 100 participants were analyzed. Results: Baseline SpO2 was 97.5 ± 1.5%, and baseline rSO2 was 77.25 ± 6.4%. During hypoxia, SpO2 dropped significantly, while rSO2 showed higher values. SpO2 recovered faster than rSO2. Deviations in rSO2 between the right and left sides during hypoxia were minimal. Lin's CCC indicated moderate to substantial concordance. NIRS measurements were more stable and less prone to disturbances, with 95 disruptions in pulse oximetry, 25 of which were potentially critical. Conclusions: NIRS is a reliable method for detecting cerebral oxygen saturation, offering significant advantages over traditional pulse oximetry in stability and reliability during hypoxia testing. NIRS is less error-prone, supporting its use for continuous monitoring in aviation settings and enhancing flight safety by providing more accurate hypoxia detection.

研究目的本研究评估了使用近红外光谱(NIRS)测量脑氧饱和度与传统脉搏血氧饱和度(SpO2)测量缺氧测试期间脑氧饱和度的适用性,旨在提高飞行操作和训练期间的安全性。材料与方法:研究对象包括 Königsbrück 航空医学培训中心 106 名 18-60 岁的学员。分别使用 INVOS™ 5100C 脑氧仪和 Masimo™ MS5 脉搏血氧仪测量脑氧饱和度 (rSO2) 和外周血氧饱和度 (SpO2)。测量分别在基线、25,000 英尺缺氧时和恢复后进行。数据分析包括回归分析、Bland-Altman 图和一致性相关系数 (CCC)。研究获得了汉诺威医学院的伦理批准。对 100 名参与者的数据进行了分析。结果基线 SpO2 为 97.5 ± 1.5%,基线 rSO2 为 77.25 ± 6.4%。缺氧时,SpO2 显著下降,而 rSO2 则显示较高值。SpO2 的恢复速度快于 rSO2。缺氧时左右两侧的 rSO2 偏差很小。Lin's CCC 显示中度到高度一致。NIRS 测量结果更稳定,不易受干扰,脉搏血氧仪有 95 次干扰,其中 25 次可能是严重干扰。结论近红外成像技术是一种检测脑氧饱和度的可靠方法,与传统的脉搏血氧仪相比,它在缺氧测试期间的稳定性和可靠性方面具有显著优势。近红外系统不易出错,可用于航空环境中的连续监测,并通过提供更准确的缺氧检测提高飞行安全。
{"title":"Comparing NIRS and Pulse Oximetry for Cerebral Oxygen Saturation During Hypoxia Testing.","authors":"Vasilios Alevizakos, Andreas Werner, Lisa-Marie Schiller, Constantin von See, Marcus Schiller","doi":"10.3390/medsci12040059","DOIUrl":"10.3390/medsci12040059","url":null,"abstract":"<p><p><b>Objective:</b> This study evaluates the suitability of cerebral oximetry using near-infrared spectroscopy (NIRS) compared to traditional pulse oximetry (SpO2) for measuring cerebral oxygen saturation during hypoxia testing, aiming to enhance safety during flight operations and training. <b>Material and Methods:</b> The study included 106 participants aged 18-60 years at the Aerospace Medicine Training Center in Königsbrück. Cerebral oxygen saturation (rSO2) and peripheral oxygen saturation (SpO2) were measured using the INVOS™ 5100C cerebral oximeter and Masimo™ MS5 pulse oximeter, respectively. Measurements were taken at baseline, during hypoxia at 25,000 feet, and post recovery. Data analysis included regression analysis, Bland-Altman plots, and concordance correlation coefficients (CCC). Ethical approval was obtained from the Hannover Medical School. Data from 100 participants were analyzed. <b>Results:</b> Baseline SpO2 was 97.5 ± 1.5%, and baseline rSO2 was 77.25 ± 6.4%. During hypoxia, SpO2 dropped significantly, while rSO2 showed higher values. SpO2 recovered faster than rSO2. Deviations in rSO2 between the right and left sides during hypoxia were minimal. Lin's CCC indicated moderate to substantial concordance. NIRS measurements were more stable and less prone to disturbances, with 95 disruptions in pulse oximetry, 25 of which were potentially critical. <b>Conclusions:</b> NIRS is a reliable method for detecting cerebral oxygen saturation, offering significant advantages over traditional pulse oximetry in stability and reliability during hypoxia testing. NIRS is less error-prone, supporting its use for continuous monitoring in aviation settings and enhancing flight safety by providing more accurate hypoxia detection.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587096/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142711929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experience of Hereditary Amyloidosis with Rare Variant in Ecuador: Case Reports. 厄瓜多尔罕见变异型遗传性淀粉样变性病的经验:病例报告。
Q1 Medicine Pub Date : 2024-10-21 DOI: 10.3390/medsci12040058
Diana Elizabeth Luzuriaga Carpio, Borys Roberto Abrigo Maldonado, Humberto Villacorta

More than approximately 120 transthyretin mutations are known. Their clinical presentation is heterogeneous, as the course of disease onset depends on genetic variation and level of penetrance. They are little known in Ecuador, and some of the reported cases suggest-given analysis of family trees-that they come from a province that is possibly considered endemic. The main objective of this study is to perform a descriptive observational analysis on the presentation of transthyretin amyloidosis in families carrying the p.Ser43Asn gene of the identified index case.

目前已知的转甲状腺素突变约有 120 多种。它们的临床表现各不相同,因为发病过程取决于基因变异和渗透程度。厄瓜多尔对这种疾病知之甚少,一些报告的病例通过分析家谱表明,他们来自一个可能被认为是地方病的省份。本研究的主要目的是对已确定的病例中携带 p.Ser43Asn 基因的家族中出现的转甲状腺素淀粉样变性进行描述性观察分析。
{"title":"Experience of Hereditary Amyloidosis with Rare Variant in Ecuador: Case Reports.","authors":"Diana Elizabeth Luzuriaga Carpio, Borys Roberto Abrigo Maldonado, Humberto Villacorta","doi":"10.3390/medsci12040058","DOIUrl":"https://doi.org/10.3390/medsci12040058","url":null,"abstract":"<p><p>More than approximately 120 transthyretin mutations are known. Their clinical presentation is heterogeneous, as the course of disease onset depends on genetic variation and level of penetrance. They are little known in Ecuador, and some of the reported cases suggest-given analysis of family trees-that they come from a province that is possibly considered endemic. The main objective of this study is to perform a descriptive observational analysis on the presentation of transthyretin amyloidosis in families carrying the p.Ser43Asn gene of the identified index case.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Invasiveness in Lepidic Pattern Adenocarcinoma of Lung: Analysis of Visual Semantic and Radiomic Features. 预测Lepidic型肺腺癌的侵袭性:视觉语义和放射学特征分析
Q1 Medicine Pub Date : 2024-10-18 DOI: 10.3390/medsci12040057
Sean F Johnson, Seyed Mohammad Hossein Tabatabaei, Grace Hyun J Kim, Bianca E Villegas, Matthew Brown, Scott Genshaft, Robert D Suh, Igor Barjaktarevic, William Dean Wallace, Fereidoun Abtin

Objectives: To differentiate invasive lepidic predominant adenocarcinoma (iLPA) from adenocarcinoma in situ (AIS)/minimally invasive adenocarcinoma (MIA) of lung utilizing visual semantic and computer-aided detection (CAD)-based texture features on subjects initially diagnosed as AIS or MIA with CT-guided biopsy.

Materials and methods: From 2011 to 2017, all patients with CT-guided biopsy results of AIS or MIA who subsequently underwent resection were identified. CT scan before the biopsy was used to assess visual semantic and CAD texture features, totaling 23 semantic and 95 CAD-based quantitative texture variables. The least absolute shrinkage and selection operator (LASSO) method or forward selection was used to select the most predictive feature and combination of semantic and texture features for detection of invasive lung adenocarcinoma.

Results: Among the 33 core needle-biopsied patients with AIS/MIA pathology, 24 (72.7%) had invasive LPA and 9 (27.3%) had AIS/MIA on resection. On CT, visual semantic features included 21 (63.6%) part-solid, 5 (15.2%) pure ground glass, and 7 (21.2%) solid nodules. LASSO selected seven variables for the model, but all were not statistically significant. "Volume" was found to be statistically significant when assessing the correlation between independent variables using the backward selection technique. The LASSO selected "tumor_Perc95", "nodule surround", "small cyst-like spaces", and "volume" when assessing the correlation between independent variables.

Conclusions: Lung biopsy results showing noninvasive LPA underestimate invasiveness. Although statistically non-significant, some semantic features showed potential for predicting invasiveness, with septal stretching absent in all noninvasive cases, and solid consistency present in a significant portion of invasive cases.

目的:区分浸润性鳞状上皮细胞癌(iLPA利用基于视觉语义和计算机辅助检测(CAD)的纹理特征,对经CT引导活检初步诊断为AIS或MIA的受试者进行肺部浸润性鳞状上皮腺癌(iLPA)与原位腺癌(AIS)/微浸润性腺癌(MIA)的鉴别:2011年至2017年,对所有在CT引导下活检结果为AIS或MIA且随后接受了切除术的患者进行了鉴定。活检前的CT扫描用于评估视觉语义和CAD纹理特征,共有23个语义变量和95个基于CAD的定量纹理变量。采用最小绝对收缩和选择算子(LASSO)法或前向选择法来选择对检测浸润性肺腺癌最具预测性的特征以及语义和纹理特征的组合:在33例核心针活检的AIS/MIA病理患者中,24例(72.7%)为浸润性肺腺癌,9例(27.3%)切除时为AIS/MIA。在 CT 上,视觉语义特征包括 21 个(63.6%)部分实性结节、5 个(15.2%)纯磨玻璃结节和 7 个(21.2%)实性结节。LASSO 为模型选择了七个变量,但所有变量都没有统计学意义。在使用后向选择技术评估自变量之间的相关性时,发现 "体积 "具有统计学意义。在评估自变量之间的相关性时,LASSO 选择了 "tumor_Perc95"、"nodule surround"、"small cyst-like spaces "和 "volume":结论:显示无创 LPA 的肺活检结果低估了侵袭性。尽管在统计学上并不显著,但一些语义特征显示出预测侵袭性的潜力,所有非侵袭性病例中都不存在隔膜伸展,而相当一部分侵袭性病例中存在实性一致性。
{"title":"Predicting Invasiveness in Lepidic Pattern Adenocarcinoma of Lung: Analysis of Visual Semantic and Radiomic Features.","authors":"Sean F Johnson, Seyed Mohammad Hossein Tabatabaei, Grace Hyun J Kim, Bianca E Villegas, Matthew Brown, Scott Genshaft, Robert D Suh, Igor Barjaktarevic, William Dean Wallace, Fereidoun Abtin","doi":"10.3390/medsci12040057","DOIUrl":"https://doi.org/10.3390/medsci12040057","url":null,"abstract":"<p><strong>Objectives: </strong>To differentiate invasive lepidic predominant adenocarcinoma (iLPA) from adenocarcinoma in situ (AIS)/minimally invasive adenocarcinoma (MIA) of lung utilizing visual semantic and computer-aided detection (CAD)-based texture features on subjects initially diagnosed as AIS or MIA with CT-guided biopsy.</p><p><strong>Materials and methods: </strong>From 2011 to 2017, all patients with CT-guided biopsy results of AIS or MIA who subsequently underwent resection were identified. CT scan before the biopsy was used to assess visual semantic and CAD texture features, totaling 23 semantic and 95 CAD-based quantitative texture variables. The least absolute shrinkage and selection operator (LASSO) method or forward selection was used to select the most predictive feature and combination of semantic and texture features for detection of invasive lung adenocarcinoma.</p><p><strong>Results: </strong>Among the 33 core needle-biopsied patients with AIS/MIA pathology, 24 (72.7%) had invasive LPA and 9 (27.3%) had AIS/MIA on resection. On CT, visual semantic features included 21 (63.6%) part-solid, 5 (15.2%) pure ground glass, and 7 (21.2%) solid nodules. LASSO selected seven variables for the model, but all were not statistically significant. \"Volume\" was found to be statistically significant when assessing the correlation between independent variables using the backward selection technique. The LASSO selected \"tumor_Perc95\", \"nodule surround\", \"small cyst-like spaces\", and \"volume\" when assessing the correlation between independent variables.</p><p><strong>Conclusions: </strong>Lung biopsy results showing noninvasive LPA underestimate invasiveness. Although statistically non-significant, some semantic features showed potential for predicting invasiveness, with septal stretching absent in all noninvasive cases, and solid consistency present in a significant portion of invasive cases.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503399/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Neutropenia on Clinical Outcomes after Lung Transplantation. 中性粒细胞减少症对肺移植临床结果的影响
Q1 Medicine Pub Date : 2024-10-16 DOI: 10.3390/medsci12040056
Raquel Sanabrias Fernández de Sevilla, Ana Concepción Sánchez Cerviño, Rosalía Laporta Hernández, Myriam Aguilar Pérez, Christian García Fadul, Sarela García-Masedo Fernández, Amelia Sánchez Guerrero, María Piedad Ussetti Gil

Background/objectives: Neutropenia is a frequent complication among solid organ transplant (SOT) recipients receiving immunosuppressive therapy and antimicrobial prophylaxis. However, there are limited studies analysing the frequency and impact of neutropenia in lung transplant recipients (LTRs). Our aim was to analyse the frequency of neutropenia, the need for granulocyte colony-stimulating factor (GCSF) treatment within the first 18 months post-transplant and its association with acute rejection, chronic lung allograft dysfunction (CLAD), overall survival and the development of infections.

Methods: This observational and retrospective study recruited 305 patients who underwent lung transplantation between 2009 and 2019, with outpatient quarterly follow-up during the first 18 months post-surgery.

Results: During this period, 51.8% of patients experienced at least one episode of neutropenia. Neutropenia was classified as mild in 50.57% of cases, moderate in 36.88% and severe in 12.54%. GCSF treatment was indicated in 23.28% of patients, with a mean dose of 3.53 units. No statistically significant association was observed between neutropenia or its severity and the development of acute rejection, CLAD or overall survival. However, the patients who received GCSF treatment had a higher mortality rate compared to those who did not. Sixteen patients (5.25%) developed infections during neutropenia, with bacterial infections being the most common.

Conclusions: Neutropenia is common in the first 18 months after lung transplantation and most episodes are mild. We did not find an association between neutropenia and acute rejection, CLAD, or mortality. However, the use of GCSF were associated with worse post-transplant survival.

背景/目的:中性粒细胞减少症是接受免疫抑制治疗和抗菌药物预防的实体器官移植(SOT)受者中经常出现的一种并发症。然而,分析肺移植受者(LTR)中性粒细胞减少症发生频率和影响的研究却很有限。我们的目的是分析中性粒细胞减少症的发生频率、移植后头18个月内对粒细胞集落刺激因子(GCSF)治疗的需求及其与急性排斥反应、慢性肺移植功能障碍(CLAD)、总体存活率和感染发生的关系:这项观察性和回顾性研究招募了305名在2009年至2019年期间接受肺移植的患者,在手术后的前18个月进行门诊季度随访:在此期间,51.8%的患者至少出现过一次中性粒细胞减少症。50.57%的患者中性粒细胞减少为轻度,36.88%为中度,12.54%为重度。23.28%的患者需要接受 GCSF 治疗,平均剂量为 3.53 单位。中性粒细胞减少症或其严重程度与急性排斥反应的发生、CLAD或总存活率之间没有统计学意义上的关联。不过,与未接受 GCSF 治疗的患者相比,接受 GCSF 治疗的患者死亡率较高。16名患者(5.25%)在中性粒细胞减少期间出现感染,其中细菌感染最为常见:结论:中性粒细胞减少症在肺移植术后的前18个月很常见,而且大多数情况都很轻微。我们没有发现中性粒细胞减少与急性排斥反应、CLAD或死亡率之间存在关联。不过,使用 GCSF 与移植后存活率降低有关。
{"title":"Impact of Neutropenia on Clinical Outcomes after Lung Transplantation.","authors":"Raquel Sanabrias Fernández de Sevilla, Ana Concepción Sánchez Cerviño, Rosalía Laporta Hernández, Myriam Aguilar Pérez, Christian García Fadul, Sarela García-Masedo Fernández, Amelia Sánchez Guerrero, María Piedad Ussetti Gil","doi":"10.3390/medsci12040056","DOIUrl":"10.3390/medsci12040056","url":null,"abstract":"<p><strong>Background/objectives: </strong>Neutropenia is a frequent complication among solid organ transplant (SOT) recipients receiving immunosuppressive therapy and antimicrobial prophylaxis. However, there are limited studies analysing the frequency and impact of neutropenia in lung transplant recipients (LTRs). Our aim was to analyse the frequency of neutropenia, the need for granulocyte colony-stimulating factor (GCSF) treatment within the first 18 months post-transplant and its association with acute rejection, chronic lung allograft dysfunction (CLAD), overall survival and the development of infections.</p><p><strong>Methods: </strong>This observational and retrospective study recruited 305 patients who underwent lung transplantation between 2009 and 2019, with outpatient quarterly follow-up during the first 18 months post-surgery.</p><p><strong>Results: </strong>During this period, 51.8% of patients experienced at least one episode of neutropenia. Neutropenia was classified as mild in 50.57% of cases, moderate in 36.88% and severe in 12.54%. GCSF treatment was indicated in 23.28% of patients, with a mean dose of 3.53 units. No statistically significant association was observed between neutropenia or its severity and the development of acute rejection, CLAD or overall survival. However, the patients who received GCSF treatment had a higher mortality rate compared to those who did not. Sixteen patients (5.25%) developed infections during neutropenia, with bacterial infections being the most common.</p><p><strong>Conclusions: </strong>Neutropenia is common in the first 18 months after lung transplantation and most episodes are mild. We did not find an association between neutropenia and acute rejection, CLAD, or mortality. However, the use of GCSF were associated with worse post-transplant survival.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Therapeutic Approach for Obesity: Seaweeds as an Alternative Medicine with the Latest Conventional Therapy. 肥胖症的新治疗方法:海藻作为一种替代药物与最新的传统疗法。
Q1 Medicine Pub Date : 2024-10-13 DOI: 10.3390/medsci12040055
Rajesh Yadav, Ankita Nigam, Richa Mishra, Saurabh Gupta, Anis Ahmad Chaudhary, Salah-Ud-Din Khan, Eman Abdullah Almuqri, Zakir Hassain Ahmed, Sarvesh Rustagi, Deependra Pratap Singh, Sanjay Kumar

The prevalence of overweight and obesity is increasing worldwide. Common comorbidities related to obesity, significantly polygenic disorders, cardiovascular disease, and heart conditions affect social and monetary systems. Over the past decade, research in drug discovery and development has opened new paths for alternative and conventional medicine. With a deeper comprehension of its underlying mechanisms, obesity is now recognized more as a chronic condition rather than merely a result of lifestyle choices. Nonetheless, addressing it solely through lifestyle changes is challenging due to the intricate nature of energy regulation dysfunction. The Federal Drug Administration (FDA) has approved six medications for the management of overweight and obesity. Seaweed are plants and algae that grow in oceans, rivers, and lakes. Studies have shown that seaweed has therapeutic potential in the management of body weight and obesity. Seaweed compounds such as carotenoids, xanthophyll, astaxanthin, fucoidans, and fucoxanthin have been demonstrated as potential bioactive components in the treatment of obesity. The abundance of natural seaweed bioactive compounds has been explored for their therapeutic potential for treating obesity worldwide. Keeping this view, this review covered the latest developments in the discovery of varied anti-obese seaweed and its bioactive components for the management of obesity.

超重和肥胖症的发病率在全球范围内不断上升。与肥胖有关的常见并发症,特别是多基因疾病、心血管疾病和心脏病影响着社会和货币体系。在过去十年中,药物发现和开发研究为替代医学和传统医学开辟了新的道路。随着人们对肥胖症的内在机制有了更深入的了解,肥胖症现在被认为是一种慢性疾病,而不仅仅是生活方式选择的结果。然而,由于能量调节功能障碍的复杂性,仅通过改变生活方式来解决肥胖问题具有挑战性。美国联邦药品管理局(FDA)已批准六种药物用于治疗超重和肥胖症。海藻是生长在海洋、河流和湖泊中的植物和藻类。研究表明,海藻在控制体重和肥胖方面具有治疗潜力。类胡萝卜素、黄绿素、虾青素、褐藻糖胶和岩藻黄素等海藻化合物已被证明是治疗肥胖症的潜在生物活性成分。全世界都在探索天然海藻生物活性化合物治疗肥胖症的潜力。有鉴于此,本综述介绍了在发现各种抗肥胖海藻及其生物活性成分以治疗肥胖症方面的最新进展。
{"title":"Novel Therapeutic Approach for Obesity: Seaweeds as an Alternative Medicine with the Latest Conventional Therapy.","authors":"Rajesh Yadav, Ankita Nigam, Richa Mishra, Saurabh Gupta, Anis Ahmad Chaudhary, Salah-Ud-Din Khan, Eman Abdullah Almuqri, Zakir Hassain Ahmed, Sarvesh Rustagi, Deependra Pratap Singh, Sanjay Kumar","doi":"10.3390/medsci12040055","DOIUrl":"https://doi.org/10.3390/medsci12040055","url":null,"abstract":"<p><p>The prevalence of overweight and obesity is increasing worldwide. Common comorbidities related to obesity, significantly polygenic disorders, cardiovascular disease, and heart conditions affect social and monetary systems. Over the past decade, research in drug discovery and development has opened new paths for alternative and conventional medicine. With a deeper comprehension of its underlying mechanisms, obesity is now recognized more as a chronic condition rather than merely a result of lifestyle choices. Nonetheless, addressing it solely through lifestyle changes is challenging due to the intricate nature of energy regulation dysfunction. The Federal Drug Administration (FDA) has approved six medications for the management of overweight and obesity. Seaweed are plants and algae that grow in oceans, rivers, and lakes. Studies have shown that seaweed has therapeutic potential in the management of body weight and obesity. Seaweed compounds such as carotenoids, xanthophyll, astaxanthin, fucoidans, and fucoxanthin have been demonstrated as potential bioactive components in the treatment of obesity. The abundance of natural seaweed bioactive compounds has been explored for their therapeutic potential for treating obesity worldwide. Keeping this view, this review covered the latest developments in the discovery of varied anti-obese seaweed and its bioactive components for the management of obesity.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-Step Cannulation and Distance Measurement during Aortic Branched Endograft Repair: The Neuron Catheter Trick. 主动脉分支内移植物修复过程中的一步插管和距离测量:神经元导管技巧。
Q1 Medicine Pub Date : 2024-10-06 DOI: 10.3390/medsci12040054
Gioele Simonte, Gianluigi Fino, Gianbattista Parlani, Rachele Simonte, Giacomo Isernia

Purpose: This paper aims to describe a straightforward, efficient, and reliable technique to simplify cannulation maneuvers during aortic branched endograft repair.

Technique: The suggested approach utilizes the Penumbra Neuron Select catheter, which combines diagnostic, sizing, and support capabilities in one. This has the potential to reduce procedural time and minimize the need for serial catheter and guidewire exchanges.

Conclusions: The proposed technique offers a simple yet effective tool to mitigate the risk of vessel loss and injury, and to streamline complex aortic repair procedures.

目的:本文旨在描述一种简单、高效、可靠的技术,以简化主动脉分支内膜移植修复过程中的插管操作:建议采用的方法利用了集诊断、尺寸测量和支持功能于一体的 Penumbra Neuron Select 导管。这有可能缩短手术时间,最大限度地减少连续更换导管和导丝的需要:结论:所提出的技术提供了一种简单而有效的工具,可降低血管缺失和损伤的风险,并简化复杂的主动脉修复手术。
{"title":"One-Step Cannulation and Distance Measurement during Aortic Branched Endograft Repair: The Neuron Catheter Trick.","authors":"Gioele Simonte, Gianluigi Fino, Gianbattista Parlani, Rachele Simonte, Giacomo Isernia","doi":"10.3390/medsci12040054","DOIUrl":"https://doi.org/10.3390/medsci12040054","url":null,"abstract":"<p><strong>Purpose: </strong>This paper aims to describe a straightforward, efficient, and reliable technique to simplify cannulation maneuvers during aortic branched endograft repair.</p><p><strong>Technique: </strong>The suggested approach utilizes the Penumbra Neuron Select catheter, which combines diagnostic, sizing, and support capabilities in one. This has the potential to reduce procedural time and minimize the need for serial catheter and guidewire exchanges.</p><p><strong>Conclusions: </strong>The proposed technique offers a simple yet effective tool to mitigate the risk of vessel loss and injury, and to streamline complex aortic repair procedures.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Increasing Problem of Resistant Hypertension: We'll Manage till Help Comes! 顽固性高血压问题日益严重:在救援来临之前,我们将设法应对!
Q1 Medicine Pub Date : 2024-10-04 DOI: 10.3390/medsci12040053
Francesco Natale, Rosa Franzese, Ettore Luisi, Noemi Mollo, Luigi Marotta, Achille Solimene, Saverio D'Elia, Paolo Golino, Giovanni Cimmino

Arterial hypertension remains the major cardiovascular risk worldwide. It is estimated that under 50 years of age one in every three adults is hypertensive while beyond the age of 50 the prevalence is almost 50% globally. The latest World Health Organization (WHO) Global Report on Hypertension indicated that the global number of hypertensive patients almost doubled in the last three decades, with related increasing deaths, disability, and costs annually. Because of this global increase, early diagnosis and timely treatment is of great importance. However, based on the WHO Global Report, it is estimated that up to 46% of individuals were never diagnosed. Of those diagnosed, less than 50% were on treatment, with nearly half among these at target according to the current guidelines. It is also important to note that an increasing number of hypertensive patients, despite the use of three or more drugs, still do not achieve a blood pressure normalization, thus defining the clinical scenario of resistant hypertension (RH). This condition is associated to a higher risk of hypertension-mediated organ damage and hospitalization due to acute cardiovascular events. Current guidelines recommend a triple combination therapy (renin angiotensin system blocking agent + a thiazide or thiazide-like diuretic + a dihydropyridinic calcium-channel blocker) to all patients with RH. Beta-blockers and mineralocorticoid receptor antagonists, alone or in combination, should be also considered based on concomitant conditions and potential contraindications. Finally, the renal denervation is also proposed in patients with preserved kidney function that remain hypertensive despite the use of maximum tolerated medical treatment. However, the failure of this procedure in the long term and the contraindication in patients with kidney failure is a strong call for a new therapeutic approach. In the present review, we will discuss the pharmacological novelties to come for the management of hypertension and RH in the next future.

动脉高血压仍然是全球主要的心血管风险。据估计,在 50 岁以下的人群中,每三个成年人中就有一人患有高血压,而 50 岁以上人群的发病率几乎占全球的 50%。世界卫生组织(WHO)最新发布的《全球高血压报告》指出,在过去三十年中,全球高血压患者人数几乎翻了一番,相关的死亡、残疾和费用每年都在增加。由于这一全球性增长,早期诊断和及时治疗显得尤为重要。然而,根据世界卫生组织的全球报告,估计有高达 46% 的人从未得到诊断。在已确诊的患者中,只有不到 50%的人在接受治疗,而根据现行指南,其中近一半的人处于目标治疗阶段。还必须指出的是,越来越多的高血压患者尽管使用了三种或三种以上的药物,但仍无法实现血压正常化,这就是耐药性高血压(RH)的临床表现。这种情况与高血压引起的器官损伤和急性心血管事件导致的住院风险较高有关。目前的指南建议所有 RH 患者接受三联疗法(肾素血管紧张素系统阻断剂+噻嗪类或噻嗪类利尿剂+二氢吡啶钙通道阻滞剂)。还应根据并发症和潜在禁忌症考虑单独或联合使用β-受体阻滞剂和矿皮质激素受体拮抗剂。最后,还建议对肾功能保留但在使用最大耐受药物治疗后仍有高血压的患者进行肾脏去神经支配。然而,这种手术的长期失败以及肾功能衰竭患者的禁忌症强烈要求采用新的治疗方法。在本综述中,我们将讨论未来治疗高血压和肾功能衰竭的新药。
{"title":"The Increasing Problem of Resistant Hypertension: We'll Manage till Help Comes!","authors":"Francesco Natale, Rosa Franzese, Ettore Luisi, Noemi Mollo, Luigi Marotta, Achille Solimene, Saverio D'Elia, Paolo Golino, Giovanni Cimmino","doi":"10.3390/medsci12040053","DOIUrl":"https://doi.org/10.3390/medsci12040053","url":null,"abstract":"<p><p>Arterial hypertension remains the major cardiovascular risk worldwide. It is estimated that under 50 years of age one in every three adults is hypertensive while beyond the age of 50 the prevalence is almost 50% globally. The latest World Health Organization (WHO) Global Report on Hypertension indicated that the global number of hypertensive patients almost doubled in the last three decades, with related increasing deaths, disability, and costs annually. Because of this global increase, early diagnosis and timely treatment is of great importance. However, based on the WHO Global Report, it is estimated that up to 46% of individuals were never diagnosed. Of those diagnosed, less than 50% were on treatment, with nearly half among these at target according to the current guidelines. It is also important to note that an increasing number of hypertensive patients, despite the use of three or more drugs, still do not achieve a blood pressure normalization, thus defining the clinical scenario of resistant hypertension (RH). This condition is associated to a higher risk of hypertension-mediated organ damage and hospitalization due to acute cardiovascular events. Current guidelines recommend a triple combination therapy (renin angiotensin system blocking agent + a thiazide or thiazide-like diuretic + a dihydropyridinic calcium-channel blocker) to all patients with RH. Beta-blockers and mineralocorticoid receptor antagonists, alone or in combination, should be also considered based on concomitant conditions and potential contraindications. Finally, the renal denervation is also proposed in patients with preserved kidney function that remain hypertensive despite the use of maximum tolerated medical treatment. However, the failure of this procedure in the long term and the contraindication in patients with kidney failure is a strong call for a new therapeutic approach. In the present review, we will discuss the pharmacological novelties to come for the management of hypertension and RH in the next future.</p>","PeriodicalId":74152,"journal":{"name":"Medical sciences (Basel, Switzerland)","volume":"12 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical sciences (Basel, Switzerland)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1